Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0Biomolecules

Emerging Roles of tRNA-Derived Small RNAs in Cardiovascular Diseases: Mechanistic Insights and Translational Perspectives

  1. 1Department of Cardiology, Division of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
  2. 2Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan 430030, China
  3. 3Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, 1095# Jiefang Ave, Wuhan 430030, China

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of disability and mortality worldwide, characterized by highly complex pathophysiological mechanisms involving multilayered gene regulatory networks. Despite substantial advances in related research in recent years, the annual number of CVD-related deaths continues to rise, imposing a profound and persistent global socioeconomic burden. Consequently, there is an urgent need to identify novel molecular mechanisms and therapeutic targets. As an emerging class of non-coding RNAs, tRNA-derived small RNAs (tsRNAs) have increasingly been recognized as pivotal regulators of cardiovascular homeostasis. By targeting RNA, proteins, or other molecular structures, tsRNAs are deeply involved throughout the initiation, progression, and clinical outcomes of CVDs by orchestrating key pathological processes, including mitochondrial dysfunction, metabolic reprogramming, and inflammatory responses. Meanwhile, with ongoing advances in high-throughput sequencing technologies and therapeutic development strategies, the clinical translation of tsRNAs as novel biomarkers and therapeutic targets is also accelerating. Therefore, this review aims to systematically summarize the current core consensus and the latest research advances in this field, comprehensively elucidate the specific mechanisms by which tsRNAs contribute to the pathogenesis and progression of CVDs, and provide innovative insights for the development of more effective translational strategies.

Related

  1. Multipath interaction network of annexin A2: multifaceted regulation and translational perspectives in neurological diseases
    Yong Guan, Ping Gu, Dachuang Guo +5
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. Crosstalk between ubiquitination and other post-translational modifications in cardiovascular diseases.
    Yi Yan, Zhiqiang Li, Tingting Xiao
    ISciencePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  3. Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives
    Roko Šantić, Lovre Martinovic, Nikola Pavlović +5
    MoleculesPeer-reviewedCC BY9 citedMolecular biology & gene regulationOpenAlex
  4. MitoQ in sepsis-associated acute lung injury: redox pharmacology, mechanistic evidence, and translational perspectives
    Jiajia Yu, Yuyu An, Yanni Mi +3
    Frontiers in pharmacologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  5. Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges
    Min Qiao, Chang Sun, Yangyang Qin +5
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
BibTeX
@article{wen2026emerging,
  title = {{Emerging Roles of tRNA-Derived Small RNAs in Cardiovascular Diseases: Mechanistic Insights and Translational Perspectives}},
  author = {Yi Wen and Xiaozhu Ma and Shuai Mei and Qidamugai Wuyun and Zixuan Zhang and Qiushi Luo and Li Zhou and Tao Mi and Jiangtao Yan},
  journal = {Biomolecules},
  year = {2026},
  month = nov,
  doi = {10.3390/biom16111640},
  url = {https://www.mdpi.com/2218-273X/16/11/1640},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Emerging Roles of tRNA-Derived Small RNAs in Cardiovascular Diseases: Mechanistic Insights and Translational Perspectives
AU  - Yi Wen
AU  - Xiaozhu Ma
AU  - Shuai Mei
AU  - Qidamugai Wuyun
AU  - Zixuan Zhang
AU  - Qiushi Luo
AU  - Li Zhou
AU  - Tao Mi
AU  - Jiangtao Yan
PY  - 2026
DA  - 2026/11/10
JO  - Biomolecules
DO  - 10.3390/biom16111640
UR  - https://www.mdpi.com/2218-273X/16/11/1640
AB  - Cardiovascular diseases (CVDs) remain the leading cause of disability and mortality worldwide, characterized by highly complex pathophysiological mechanisms involving multilayered gene regulatory networks. Despite substantial advances in related research in recent years, the annual number of CVD-related deaths continues to rise, imposing a profound and persistent global socioeconomic burden. Consequently, there is an urgent need to identify novel molecular mechanisms and therapeutic targets. As an emerging class of non-coding RNAs, tRNA-derived small RNAs (tsRNAs) have increasingly been recognized as pivotal regulators of cardiovascular homeostasis. By targeting RNA, proteins, or other molecular structures, tsRNAs are deeply involved throughout the initiation, progression, and clinical outcomes of CVDs by orchestrating key pathological processes, including mitochondrial dysfunction, metabolic reprogramming, and inflammatory responses. Meanwhile, with ongoing advances in high-throughput sequencing technologies and therapeutic development strategies, the clinical translation of tsRNAs as novel biomarkers and therapeutic targets is also accelerating. Therefore, this review aims to systematically summarize the current core consensus and the latest research advances in this field, comprehensively elucidate the specific mechanisms by which tsRNAs contribute to the pathogenesis and progression of CVDs, and provide innovative insights for the development of more effective translational strategies.
SN  - 2218-273X
ER  -